(Q44187288)

30 November 2017

Sodium valproate prophylaxis in childhood migraine (English)

1 reference

30 November 2017

1 reference

Gul Serdaroglu

1

1 reference

30 November 2017

Elvan Erhan

2

1 reference

30 November 2017

Hasan Tekgul

3

1 reference

30 November 2017

Figen Oksel

4

1 reference

30 November 2017

Serpil Erermis

5

1 reference

30 November 2017

Meltem Uyar

6

1 reference

30 November 2017

Sarenur Tutuncuoglu

7

1 reference

30 November 2017

1 September 2002

1 reference

30 November 2017

1 reference

30 November 2017

42

1 reference

30 November 2017

8

1 reference

30 November 2017

819-822

1 reference

Prevalence of headache and migraine in schoolchildren

30 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02186.X

Pediatric migraine and the International Headache Society (IHS) criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02186.X

Valproate: a new drug in migraine prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02186.X

Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02186.X

Headaches and women: treatment of the pregnant and lactating migraineur

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02186.X

Divalproex sodium in migraine prophylaxis: a dose-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02186.X

Valproic acid in prophylaxis of refractory migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02186.X

Valproic acid treatment of chronic daily headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02186.X

An analysis of the "carry-over effect" following successful short-term treatment of transformed migraine with divalproex sodium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02186.X

The efficacy of divalproex sodium in the prophylactic treatment of children with migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02186.X

Genetic and environmental factors associated with migraine in schoolchildren

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02186.X

Prevention of migraine by reducing prolactin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02186.X

21 January 2018

Prolactin and migraine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02186.X

Valproate in the treatment of persistent chronic daily headache. An open label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2002.02186.X

10.1046/J.1526-4610.2002.02186.X

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference